Bank of America’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431K Sell
57,011
-14,916
-21% -$113K ﹤0.01% 4882
2025
Q1
$397K Buy
71,927
+63,905
+797% +$353K ﹤0.01% 4853
2024
Q4
$46.1K Sell
8,022
-701,630
-99% -$4.03M ﹤0.01% 5758
2024
Q3
$7.35M Buy
709,652
+113,739
+19% +$1.18M ﹤0.01% 2881
2024
Q2
$7.73M Buy
595,913
+79,547
+15% +$1.03M ﹤0.01% 2755
2024
Q1
$9.02M Buy
516,366
+504,106
+4,112% +$8.8M ﹤0.01% 2624
2023
Q4
$115K Buy
12,260
+1,643
+15% +$15.5K ﹤0.01% 5403
2023
Q3
$119K Sell
10,617
-45,105
-81% -$504K ﹤0.01% 5306
2023
Q2
$1.19M Sell
55,722
-166,986
-75% -$3.57M ﹤0.01% 3896
2023
Q1
$9.01M Buy
222,708
+167,431
+303% +$6.77M ﹤0.01% 2507
2022
Q4
$2.57M Buy
55,277
+11,370
+26% +$529K ﹤0.01% 3471
2022
Q3
$2.28M Buy
43,907
+31,273
+248% +$1.62M ﹤0.01% 3543
2022
Q2
$597K Sell
12,634
-25,114
-67% -$1.19M ﹤0.01% 4611
2022
Q1
$2.69M Buy
37,748
+19,154
+103% +$1.36M ﹤0.01% 3715
2021
Q4
$1.39M Buy
18,594
+10,273
+123% +$768K ﹤0.01% 4243
2021
Q3
$472K Buy
8,321
+1,104
+15% +$62.6K ﹤0.01% 4897
2021
Q2
$317K Sell
7,217
-691
-9% -$30.4K ﹤0.01% 5023
2021
Q1
$391K Buy
7,908
+462
+6% +$22.8K ﹤0.01% 4937
2020
Q4
$314K Sell
7,446
-1,217
-14% -$51.3K ﹤0.01% 4609
2020
Q3
$397K Sell
8,663
-3,167
-27% -$145K ﹤0.01% 4316
2020
Q2
$595K Sell
11,830
-18,954
-62% -$953K ﹤0.01% 3993
2020
Q1
$1.58M Buy
30,784
+20,471
+198% +$1.05M ﹤0.01% 3241
2019
Q4
$637K Sell
10,313
-1,383
-12% -$85.4K ﹤0.01% 4140
2019
Q3
$704K Sell
11,696
-30,089
-72% -$1.81M ﹤0.01% 4118
2019
Q2
$3.53M Buy
41,785
+12,483
+43% +$1.05M ﹤0.01% 3046
2019
Q1
$2.8M Buy
29,302
+21,426
+272% +$2.05M ﹤0.01% 3194
2018
Q4
$558K Buy
7,876
+369
+5% +$26.1K ﹤0.01% 4202
2018
Q3
$642K Sell
7,507
-5,361
-42% -$458K ﹤0.01% 4125
2018
Q2
$1.49M Sell
12,868
-7,155
-36% -$830K ﹤0.01% 3615
2018
Q1
$1.62M Buy
20,023
+4,078
+26% +$330K ﹤0.01% 3500
2017
Q4
$935K Sell
15,945
-5,576
-26% -$327K ﹤0.01% 3854
2017
Q3
$1.01M Buy
21,521
+703
+3% +$32.9K ﹤0.01% 3843
2017
Q2
$749K Sell
20,818
-32,656
-61% -$1.17M ﹤0.01% 3975
2017
Q1
$1.65M Buy
53,474
+34,429
+181% +$1.06M ﹤0.01% 3461
2016
Q4
$638K Buy
19,045
+13,039
+217% +$437K ﹤0.01% 3963
2016
Q3
$159K Sell
6,006
-208,079
-97% -$5.51M ﹤0.01% 4501
2016
Q2
$4.72M Sell
214,085
-112,947
-35% -$2.49M ﹤0.01% 2383
2016
Q1
$9.61M Buy
327,032
+28,672
+10% +$842K ﹤0.01% 1840
2015
Q4
$9.85M Sell
298,360
-24,498
-8% -$809K ﹤0.01% 1849
2015
Q3
$11.7M Buy
322,858
+303,667
+1,582% +$11M ﹤0.01% 1712
2015
Q2
$863K Buy
19,191
+13,125
+216% +$590K ﹤0.01% 3391
2015
Q1
$186K Sell
6,066
-1,135
-16% -$34.8K ﹤0.01% 4057
2014
Q4
$367K Sell
7,201
-479
-6% -$24.4K ﹤0.01% 3794
2014
Q3
$304K Buy
7,680
+7,581
+7,658% +$300K ﹤0.01% 3808
2014
Q2
$4K Sell
99
-569
-85% -$23K ﹤0.01% 5775
2014
Q1
$27K Sell
668
-2,267
-77% -$91.6K ﹤0.01% 5009
2013
Q4
$80K Buy
2,935
+2,909
+11,188% +$79.3K ﹤0.01% 4657
2013
Q3
$1K Sell
26
-4,849
-99% -$187K ﹤0.01% 5812
2013
Q2
$86K Buy
+4,875
New +$86K ﹤0.01% 4832